A complex mechanism for inducer mediated tau polymerization

Biochemistry

Volumn 46, Issue 30, 2007, Pages 8838-8849

  Carlson, Shaun W ^a   Branden, Mike ^a   Voss, Kellen ^a   Sun, Qian ^a   Rankin, Carolyn A ^a   Gamblin, T Chris ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGANDS; MOLECULAR DYNAMICS; POLYMERIZATION; PROTEINS;

INDUCERS; NEURODEGENERATION; PROTEIN TAU; TAU POLYMERIZATION;

ORGANIC POLYMERS;

ARACHIDONIC ACID; HEPARIN; MICROTUBULE ASSOCIATED PROTEIN; TAU PROTEIN;

ALLOSTERISM; ALZHEIMER DISEASE; ARTICLE; CONFORMATIONAL TRANSITION; PRIORITY JOURNAL; PROTEIN POLYMERIZATION; STEADY STATE; TAUOPATHY; THERMODYNAMICS;

ALLOSTERIC REGULATION; ARACHIDONIC ACID; BINDING SITES; HEPARIN; HUMANS; KINETICS; LASERS; MODELS, MOLECULAR; MODELS, NEUROLOGICAL; NEUROFIBRILLARY TANGLES; POLYMERS; PROTEIN BINDING; RECOMBINANT PROTEINS; SCATTERING, RADIATION; TAU PROTEINS;

EID: 34547620334     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi700403a     Document Type: Article

References (46)

1. Lee, V. M., Goedert, M., and Trojanowski, J. Q. (2001) Neurodegenerative tauopathies, Annu. Rev. Neurosci. 24, 1121-1159.
2. Sergeant, N., Delacourte, A., and Buee, L. (2005) Tau protein as a differential biomarker of tauopathies, Biochim. Biophys. Acta 1739, 179-197.
3. Gamblin, T. C., Berry, R. W., and Binder, L. I. (2003) Modeling tau polymerization in vitro: a review and synthesis, Biochemistry 42, 15009-15017.
4. Kuret, J., Chirita, C. N., Congdon, E. E., Kannanayakal, T., Li, G., Necula, M., Yin, H., and Zhong, Q. (2005) Pathways of tau fibrillization, Biochim. Biophys. Acta 1739, 167-178.
5. Barghorn, S., and Mandelkow, E. (2002) Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments, Biochemistry 41, 14885-14896.
6. Friedhoff, P., von Bergen, M., Mandelkow, E., and Davies, P. (1998) A nucleated assembly mechanism of alzheimer paired helical filaments, Proc. Natl. Acad. Sci. U.S.A. 95, 15712-15717.
7. Chirita, C. N., Congdon, E. E., Yin, H., and Kuret, J. (2005) Triggers of full-length tau aggregation: a role for partially folded intermediates, Biochemistry 44, 5862-5872.
8. Chirita, C. N., and Kuret, J. (2004) Evidence for an intermediate in tau filament formation, Biochemistry 43, 1704-1714.
9. King, M. E., Ahuja, V., Binder, L. I., and Kuret, J. (1999) Ligand-dependent tau filament formation: Implications for Alzheimer's disease progression, Biochemistry 38, 14851-14859.
10. Friedhoff, P., Schneider, A., Mandelkow, E. M., and Mandelkow, E. (1998) Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution, Biochemistry 37, 10223-10230.
11. Gamblin, T. C., King, M. E., Dawson, H., Vitek, M. P., Kuret, J., Beny, R. W., and Binder, L. I. (2000) In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants, Biochemistry 39, 6136-6144.
12. Oosawa, F., and Asakura, S. (1975) Thermodynamics of the Polymerization of Protein, Academic Press, London.
13. Rankin, C. A., Sun, Q., and Gamblin, T. C. (2005) Pseudophosphorylation of tau at Ser202 and Thr205 affects tau filament formation, Brain Res. Mol. Brain. Res. 138, 84-93.
14. DeTure, M., Granger, B., Grover, A., Hutton, M., and Yen, S. H. (2006) Evidence for independent mechanisms and a multiple-hit model of tau assembly, Biochem. Biophys. Res. Commun. 339, 858-864.
15. Horowitz, P. M., Lapointe, N., Guillozet-Bongaarts, A. L., Berry, R. W., and Binder, L. I. (2006) N-terminal fragments of tau inhibit full-length tau polymerization in vitro, Biochemistry 45, 12859-12866.
16. Chirita, C. N., Necula, M., and Kuret, J. (2003) Anionic micelles and vesicles induce tau fibrillization in vitro, J. Biol. Chem. 278, 25644-25650.
17. Necula, M., and Kuret, J. (2004) A static laser light scattering assay for surfactant-induced tau fibrillization, Anal. Biochem. 333, 205-215.
18. von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., and Mandelkow, E. (2000) Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming beta structure, Proc. Natl. Acad. Sci. U.S.A. 97, 5129-5134.
19. Wille, H., Drewes, G., Biernat, J., Mandelkow, E. M., and Mandelkow, E. (1992) Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro, J. Cell Biol. 118, 573-584.
20. Necula, M., Chirita, C. N., and Kuret, J. (2005) Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases, Biochemistry 44, 10227-10237.
21. Necula, M., and Kuret, J. (2004) Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro, J. Biol. Chem. 279, 49694-49703.
22. Yin, H., and Kuret, J. (2006) C-terminal truncation modulates both nucleation and extension phases of tau fibrillization, FEBS Lett. 580, 211-215.
23. Berne, B. J. (1974) Interpretation of the light scattering from long rods, J. Mol. Biol. 89, 755-758.
24. Santa-Maria, I., Perez, M., Hernandez, F., Avila, J., and Moreno, F. J. (2006) Characteristics of the binding of thioflavin S to tau paired helical filaments, J. Alzheimer's. Dis. 9, 279-285.
25. Tobacman, L. S., and Korn, E. D. (1983) The kinetics of actin nucleation and polymerization, J. Biol. Chem. 258, 3207-3214.
26. von Bergen, M., Barghorn, S., Muller, S. A., Pickhardt, M., Biernat, J., Mandelkow, E. M., Davies, P., Aebi, U., and Mandelkow, E. (2006) The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis, Biochemistry 45, 6446-6457.
27. Ko, L. W., DeTure, M., Sahara, N., Chihab, R., Vega, I. E., and Yen, S. H. (2005) Recent advances in experimental modeling of the assembly of tau filaments, Biochim. Biophys. Acta 1739, 125-139.
28. Reynolds, M. R., Berry, R. W., and Binder, L. I. (2005) Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer's disease, Biochemistry 44, 1690-1700.
29. Maeda, S., Sahara, N., Saito, Y., Murayama, S., Ikai, A., and Takashima, A. (2006) Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease, Neurosci. Res. 54, 197-201.
30. Glabe, C. G. (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease, Neurobiol. Aging 27, 570-575.
31. von Bergen, M., Barghorn, S., Biernat, J., Mandelkow, E. M., and Mandelkow, E. (2005) Tau aggregation is driven by a transition from random coil to beta sheet structure, Biochim. Biophys. Acta 1739, 158-166.
32. Barghorn, S., Davies, P., and Mandelkow, E. (2004) Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain, Biochemistry 43, 1694-1703.
33. Gamblin, T. C., King, M. E., Kuret, J., Berry, R. W., and Binder, L. I. (2000) Oxidative regulation of fatty acid-induced tau polymerization, Biochemistry 39, 14203-14210.
34. Farooqui, A. A., and Horrocks, L. A. (2006) Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly, Neuroscientist 12, 245-260.
35. Pratico, D., V, M. Y. L., Trojanowski, J. Q., Rokach, J., and Fitzgerald, G. A. (1998) Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo, FASEB J. 12, 1777-1783.
36. Reich, E. E., Markesbery, W. R., Roberts, L. J., II, Swift, L. L., Morrow, J. D., and Montine, T. J. (2001) Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease, Am. J. Pathol. 158, 293-297.
37. Roberts, L. J., II, Montine, T. J., Markesbery, W. R., Tapper, A. R., Hardy, P., Chemtob, S., Dettbarn, W. D., and Morrow, J. D. (1998) Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid, J. Biol Chem. 273, 13605-13612.
38. Markesbery, W. R., and Carney, J. M. (1999) Oxidative alterations in Alzheimer's disease, Brain Pathol. 9, 133-146.
39. Montine, K. S., Kim, P. J., Olson, S. J., Markesbery, W. R., and Montine, T. J. (1997) 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease, J. Neuropathol. Exp. Neurol. 56, 866-871.
40. Perez, M., Hernandez, F., Gomez-Ramos, A., Smith, M., Perry, G., and Avila, J. (2002) Formation of aberrant phosphotau fibrillar polymers in neural cultured cells, Eur. J. Biochem. 269, 1484-1489.
41. Santa-Maria, I., Hernandez, F., Martin, C. P., Avila, J., and Moreno, F. J. (2004) Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers, Biochemistry 43, 2888-2897.
42. Diaz-Nido, J., Wandosell, F., and Avila, J. (2002) Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases, Peptides 23, 1323-1332.
43. Su, J. H., Cummings, B. J., and Cotman, C. W. (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease, Neuroscience 51, 801-813.
44. Alonso, A., Zaidi, T., Novak, M., Grundke-Iqbal, I., and Iqbal, K. (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments, Proc. Natl. Acad. Sci. U.S.A. 98, 6923-6928.
45. Alonso, A. C., Grundke-Iqbal, I., and Iqbal, K. (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules, Nat. Med. 2, 783-787.
46. Kasai, M., and Oosawa, F. (1963) Removal of nucleotides from F-actin, Biochim. Biophys. Acta 75, 223-233.